Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EC1456 |
Synonyms | |
Therapy Description |
EC1456 is a small molecule drug comprised of folate (vitamin B9) linked to the cytotoxic agent, tubulysin B hydrazide, which is internalized by folate receptor-expressing tumor cells to inhibit microtubule polymerization thereby, inhibiting cell cycle progression and inducing apoptosis (PMID: 29895863, PMID: 32728172). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EC1456 | EC1456 is a small molecule drug comprised of folate (vitamin B9) linked to the cytotoxic agent, tubulysin B hydrazide, which is internalized by folate receptor-expressing tumor cells to inhibit microtubule polymerization thereby, inhibiting cell cycle progression and inducing apoptosis (PMID: 29895863, PMID: 32728172). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01999738 | Phase I | EC1456 | Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors | Completed | USA | 0 |